Background Background Randomised controlled
Randomised controlled trials (RCTs) are the gold standard for trials (RCTs) are the gold standard for evaluating treatment efficacy.However, evaluating treatment efficacy.However, the outcomes of RCTs often lackclinical the outcomes of RCTs often lackclinical utility and usually do not address realutility and usually do not address realworld effectiveness. world effectiveness.
Aims Aims To review how traditional RCTs
To review how traditional RCTs may be triangulated with other may be triangulated with other methodologies such as observational methodologies such as observational studies and pragmatic trials by highlighting studies and pragmatic trials by highlighting recently reported studies, outcomes used recently reported studies, outcomes used and their respective merits. and their respective merits.
Method Method Literature review focusing on
Literature review focusing on drug treatment. drug treatment.
Results

Results Recently reported
Recently reported observational and some pragmatic studies observational and some pragmatic studies show a degree of consistency in reported show a degree of consistency in reported results and use outcomes that have face results and use outcomes that have face validity for clinicians. validity for clinicians.
Conclusions Conclusions No single experimental
No single experimental paradigm or outcome provides the paradigm or outcome provides the necessary data to optimise treatment of necessary data to optimise treatment of mental illness in the clinical setting. mental illness in the clinical setting. Evaluating treatment outcomes in mental Evaluating treatment outcomes in mental illness presents unique and formidable chalillness presents unique and formidable challenges. The natural course of many psychilenges. The natural course of many psychiatric disorders is cyclical with spontaneous atric disorders is cyclical with spontaneous remission a distinct possibility (Ciompi, remission a distinct possibility (Ciompi, 1980) . Environmental factors are import-1980) . Environmental factors are important but poorly understood. Mental illness ant but poorly understood. Mental illness continues to be characterised in terms of continues to be characterised in terms of symptoms despite advances in understandsymptoms despite advances in understanding pathogenesis. Currently, most pubing pathogenesis. Currently, most published pharmacotherapy clinical trial data lished pharmacotherapy clinical trial data derive from trials performed to prove effiderive from trials performed to prove efficacy and safety to regulatory authorities. cacy and safety to regulatory authorities. Thus clinicians making treatment decisions Thus clinicians making treatment decisions are commonly presented with a series of are commonly presented with a series of randomised controlled trials (RCTs) underrandomised controlled trials (RCTs) undertaken to meet regulatory requirements, taken to meet regulatory requirements, with outcomes that are neither pragmatic with outcomes that are neither pragmatic nor easily transferable to clinical practice. nor easily transferable to clinical practice.
Declaration of interest
It is assumed that psychiatrists will base It is assumed that psychiatrists will base their treatment on the best available evitheir treatment on the best available evidence but what is the best available evidence but what is the best available evidence for a given clinician? Many factors dence for a given clinician? Many factors are relevant and include personal experiare relevant and include personal experience, the literature, anecdote, opinion ence, the literature, anecdote, opinion leaders, the pharmaceutical industry, leaders, the pharmaceutical industry, guidelines and cost. However, little is guidelines and cost. However, little is known about actual prescribing and other known about actual prescribing and other treatment decisions (Hoblyn treatment decisions (Hoblyn et al et al, 2006) . , 2006). Clinicians, purchasers and user advocates are Clinicians, purchasers and user advocates are also demanding more pragmatic end-points, also demanding more pragmatic end-points, and longer trials have shown the utility of and longer trials have shown the utility of relapse rates, hospitalisation and discharge relapse rates, hospitalisation and discharge rates as outcome measures (Csernansky rates as outcome measures (Csernansky et al et al, , 2002 (Csernansky et al et al, , ). 2002 .
Thus in 2007 'best available evidence' is Thus in 2007 'best available evidence' is generally accepted as the RCT, but the generally accepted as the RCT, but the available RCT evidence is at best incomavailable RCT evidence is at best incomplete, and at worst, flawed (Black, 1996) . plete, and at worst, flawed (Black, 1996) . The aim of this paper is to show practising The aim of this paper is to show practising clinicians the spectrum of quantitative eviclinicians the spectrum of quantitative evidence and pragmatic outcomes. dence and pragmatic outcomes.
EVOLUTION OF CLINICAL EVOLUTION OF CLINICAL TRIALS TRIALS
Since the 1940s the RCT has been the prinSince the 1940s the RCT has been the principal method of comparing the efficacy of cipal method of comparing the efficacy of all forms of medical treatment, and the all forms of medical treatment, and the basic concept has been developed and rebasic concept has been developed and refined to further reduce bias. This has been fined to further reduce bias. This has been evident in psychiatry with the development evident in psychiatry with the development of rating scales and classification systems of rating scales and classification systems which enhance reliability, if not always which enhance reliability, if not always validity. The RCT has informed the develvalidity. The RCT has informed the development of evidence-based medicine, metaopment of evidence-based medicine, metaanalysis and the Cochrane Collaboration. analysis and the Cochrane Collaboration. Evidence-based medicine resulted in part Evidence-based medicine resulted in part from the realisation that clinical from the realisation that clinical practice practice is often poorly informed by the best availis often poorly informed by the best available evidence, able evidence, and that many widely used and that many widely used treatments are either untested treatments are either untested or have been or have been shown to be ineffective (Lenzer, 2004) . shown to be ineffective (Lenzer, 2004) . Evidence-based medicine Evidence-based medicine has also been seen has also been seen as a means by which policy makers, someas a means by which policy makers, sometimes with academic support, control clinitimes with academic support, control clinical freedom ( cal freedom (Williams & Garner, 2002) . Williams & Garner, 2002) . Although RCTs have resulted in the disconAlthough RCTs have resulted in the discontinuation of fashionable but ineffective tinuation of fashionable but ineffective treatments such as insulin coma therapy treatments such as insulin coma therapy (Ackner & Oldham, 1960) , they are not (Ackner & Oldham, 1960 
R ANDOMISED CONTROLLED R ANDOMISED CONTROLLED TRIALS TRIALS
In general an RCT assesses efficacyIn general an RCT assesses efficacywhether the treatment works in a conwhether the treatment works in a controlled environment -not whether it works trolled environment -not whether it works in the real world (effectiveness) ( Table 1) . in the real world (effectiveness) ( Table 1) . Many factors affect the relationship beMany factors affect the relationship between efficacy and effectiveness. This is tween efficacy and effectiveness. This is acknowledged in the CONSORT criteria acknowledged in the CONSORT criteria for RCTs by the need to assess the generalifor RCTs by the need to assess the generalisability of the results, although a framesability of the results, although a framework for assessing and reporting this is work for assessing and reporting this is lacking (Bonell lacking (Bonell et al et al, 2006 
Patient recruitment and selection Patient recruitment and selection bias bias
Whether clinically significant selection bias Whether clinically significant selection bias occurs during recruitment to clinical trials occurs during recruitment to clinical trials is contentious. Although Burns (2006) is contentious. Although Burns (2006) reported that the basic demography of reported that the basic demography of patients in a large naturalistic study was patients in a large naturalistic study was s 7 8 s 7 8
B R I T I S H J O UR N A L O F P S YC H I AT RY B R I T I S H J O UR N A L O F P SYC H I AT RY
( 2 0 0 7 ) , 1 9 1 ( s u p p l . 5 0 ) , s 7 8^s 8 4 . d o i : 1 0 .11 9 2 / b j p .1 9 1 . 5 0 . s 7 8 , 2002) . Trials rarely report the number of patients conrarely report the number of patients considered or screened for a trial who are never sidered or screened for a trial who are never included. Although this is a CONSORT included. Although this is a CONSORT requirement, clinicians will make prerequirement, clinicians will make prescreening decisions regarding eligibility that screening decisions regarding eligibility that are never reported. This is a potential are never reported. This is a potential source of bias and might limit extrapolation source of bias and might limit extrapolation of results. It is likely that these difficulties of results. It is likely that these difficulties are a serious unreported bias in published are a serious unreported bias in published RCTs for psychological treatments. For exRCTs for psychological treatments. For example, reviews of the impact of day hospiample, reviews of the impact of day hospital treatment have failed to take entry tal treatment have failed to take entry criteria into account, leading to potentially criteria into account, leading to potentially erroneous erroneous conclusions (Thornicroft & conclusions (Thornicroft & Strathdee, 1994) . The need for informed Strathdee, 1994) . The need for informed consent might inadvertently affect the generconsent might inadvertently affect the generalisability of data from RCTs. All trials of alisability of data from RCTs. All trials of intramuscular olanzapine (Meehan intramuscular olanzapine (Meehan et al et al, , 2001; Wright 2001; Wright et al et al, 2001) were conducted , 2001) were conducted in patients who gave informed consent and, in patients who gave informed consent and, although positive, the results cannot be although positive, the results cannot be interpreted as indicating that the drug will interpreted as indicating that the drug will be as effective in patients who are highly be as effective in patients who are highly disturbed. disturbed.
Although biases are reduced in RCTs Although biases are reduced in RCTs they are not eliminated, and indeed specific they are not eliminated, and indeed specific biases may even be created. Aside from the biases may even be created. Aside from the increased practical difficulties of including increased practical difficulties of including older adults in clinical trials, only 4.2% of older adults in clinical trials, only 4.2% of older patients with major depression meet older patients with major depression meet the increasingly rigorous inclusion and the increasingly rigorous inclusion and exclusion criteria of phase 3 studies exclusion criteria of phase 3 studies (2004) reported that 25% of patients in this randomised trial had prior exposure in this randomised trial had prior exposure to one of the evaluated drugs. Generally, to one of the evaluated drugs. Generally, RCTs do not control for previous number RCTs do not control for previous number of admissions or other markers of 'difficult of admissions or other markers of 'difficult to treat' patients (Hodgson to treat' patients (Hodgson et al et al, 2005) . , 2005). This might lead to newer treatments being This might lead to newer treatments being tried in patients who are more difficult to tried in patients who are more difficult to treat, which may lead to suboptimal results treat, which may lead to suboptimal results for newer treatments (Davis for newer treatments (Davis et al et al, 2003) . , 2003). 
Rating scale outcomes Rating scale outcomes
undertook a meta-analysis of RCTs of undertook a meta-analysis of RCTs of atypical antipsychotics using reported atypical antipsychotics using reported discontinuation as an outcome and found discontinuation as an outcome and found far more variability between drugs than far more variability between drugs than might have been anticipated from the headmight have been anticipated from the headline results, which usually (marginally) line results, which usually (marginally) favour the sponsor's product (Heres favour the sponsor's product (Heres et al et al, , 2006) . Further exploration of these prag-2006). Further exploration of these pragmatic end-points in long-term studies matic end-points in long-term studies facilitate a better understanding of the face facilitate a better understanding of the face and predictive validity of rating scales. Any and predictive validity of rating scales. Any dissonance between comparator drugs using dissonance between comparator drugs using varied end-points might be cause for varied end-points might be cause for concern. A recent non-inferiority RCT comconcern. A recent non-inferiority RCT comparing two atypical antipsychotics at 1 year paring two atypical antipsychotics at 1 year showed consistency of superiority for one showed consistency of superiority for one in parameters ranging from PANSS score to in parameters ranging from PANSS score to discontinuation and hospitalisation rates discontinuation and hospitalisation rates (www.clinicalstudyresults.org/drugdetails/ (www.clinicalstudyresults.org/drugdetails/ ?drug_name_id ?drug_name_id¼187&sort-c.company_ 187&sort-c.company_ name&page name&page¼1&drug_id 1&drug_id¼509). However, 509). However, use of outcomes such as hospitalisation use of outcomes such as hospitalisation might preclude cross-service comparisons. might preclude cross-service comparisons. Quality of life has also been used as an Quality of life has also been used as an outcome but although such measures are outcome but although such measures are laudable, in practice the outcomes are diffilaudable, in practice the outcomes are difficult to measure and may not be amenable cult to measure and may not be amenable to change (Boardman to change (Boardman et al et al, 1999) . , 1999). s 7 9 s 7 9 AUTHOR'S PROOF AUTHOR'S PROOF , 2004 ). The incidence is usually reported but duration and severis usually reported but duration and severity are not. These are important variables ity are not. These are important variables and may make the difference between perand may make the difference between persevering with medication or abandoning a severing with medication or abandoning a therapeutic trial. For data such as prolactin therapeutic trial. For data such as prolactin levels RCTs often report mean cohort vallevels RCTs often report mean cohort values rather than pragmatically useful cateues rather than pragmatically useful categorical rates (Bushe & Shaw, 2007) . gorical rates (Bushe & Shaw, 2007 , 2004) . The corollary of longer study peri-2004) . The corollary of longer study periods is lower follow-up rates and, paradoxiods is lower follow-up rates and, paradoxically, high follow-up rates might be an cally, high follow-up rates might be an indicator of a biased study population. indicator of a biased study population. Drop-out rates over 6 weeks are on average Drop-out rates over 6 weeks are on average 35% and at 6 months can be around 72% 35% and at 6 months can be around 72% (Leucht (Leucht et al et al, 2003; McQuade , 2003; McQuade et al et al, 2004 McQuade et al et al, ), , 2004 ), making interpretation of data complex. making interpretation of data complex.
Randomised controlled trials are deRandomised controlled trials are designed to minimise bias and in creating this signed to minimise bias and in creating this artificial environment treatment effects artificial environment treatment effects may be obviated. Although the true maskmay be obviated. Although the true masking of many trials has been debated ing of many trials has been debated (Moncrieff, 1997), clinicians cannot inter-(Moncrieff, 1997), clinicians cannot intervene in trials in a timely or appropriate vene in trials in a timely or appropriate manner. Doses and visits are premanner. Doses and visits are predetermined, as is the ability to respond to determined, as is the ability to respond to potential side-effects. These issues are relepotential side-effects. These issues are relevant to the placebo arm, as often placebo vant to the placebo arm, as often placebo group patients are receiving a psychoactive group patients are receiving a psychoactive drug such as lorazepam (Meehan drug such as lorazepam (Meehan et al et al, , 2001; Wright 2001; Wright et al et al, 2001) . Randomised , 2001 ). Randomised controlled trials are often designed to fulfil controlled trials are often designed to fulfil regulatory requirements to obtain marketregulatory requirements to obtain marketing authorisations for a new drug. There ing authorisations for a new drug. There will be significant delays between study will be significant delays between study conception, recruitment, follow-up and conception, recruitment, follow-up and publication of results. Clinicians often anpublication of results. Clinicians often anticipate this with off-label prescribing ticipate this with off-label prescribing (Hodgson & Belgamwar, 2006) . The reality (Hodgson & Belgamwar, 2006) . The reality is that few RCTs are ever undertaken by is that few RCTs are ever undertaken by pharmaceutical companies after launch. pharmaceutical companies after launch. This is for many reasons, including the This is for many reasons, including the relatively short patent life. Thus, when such relatively short patent life. Thus, when such RCTs are performed there is often a perRCTs are performed there is often a perceived need for the data to be available ceived need for the data to be available quickly. Rarely are these trials long term. quickly. Rarely are these trials long term.
Evolution of the RCT paradigm is seen Evolution of the RCT paradigm is seen in the CATIE trial (Lieberman in the CATIE trial (Lieberman et al et al, 2005; , 2005 ; Table 2 ). In addition to traditional outcome Table 2 ). In addition to traditional outcome measures, continuation on an antipsychotic measures, continuation on an antipsychotic was used as an outcome. Such an outcome was used as an outcome. Such an outcome should resonate with clinicians as medishould resonate with clinicians as medication is most commonly discontinued owcation is most commonly discontinued owing to lack of effectiveness or side-effects ing to lack of effectiveness or side-effects (Hodgson, 2005) . Meta-analysis shows that (Hodgson, 2005) . Meta-analysis shows that lack of effectiveness is the major reason for lack of effectiveness is the major reason for discontinuation and differentiates between discontinuation and differentiates between atypical antipsychotics in RCTs. In conatypical antipsychotics in RCTs. In contrast, discontinuation for side-effects is trast, discontinuation for side-effects is relatively uniform (Kinon relatively uniform (Kinon et al et al, 2006) . , 2006). For the reasons above, RCTs fail to For the reasons above, RCTs fail to provide the clinician with all the necessary provide the clinician with all the necessary information to prescribe confidently. In orinformation to prescribe confidently. In order to prescribe a new product the clinician der to prescribe a new product the clinician uses previous experience, critical review of uses previous experience, critical review of early results and the experience of others. early results and the experience of others. In other words the clinician is in effect, alIn other words the clinician is in effect, albeit informally, undertaking a naturalistic/ beit informally, undertaking a naturalistic/ observational study. The definition of an observational study. The definition of an observational study can be problematic, observational study can be problematic, but in the context of this paper we have but in the context of this paper we have identified the key element as a research identified the key element as a research design where the design where the allocation of treatment is allocation of treatment is not fully under the control of the researcher not fully under the control of the researcher (Table 1) . (Table 1) .
OBSERVATIONAL STUDIES OBSERVATIONAL STUDIES Limitations Limitations
There are notable long-term observational There are notable long-term observational follow-up studies in psychiatry (Ciompi, follow-up studies in psychiatry (Ciompi, 1980; Harding, 1988) which illustrate the 1980; Harding, 1988) which illustrate the natural history of schizophrenia over decnatural history of schizophrenia over decades. Given this expertise, it is perhaps surades. Given this expertise, it is perhaps surprising that there are so few studies looking prising that there are so few studies looking at treatment effects over the longer term, at treatment effects over the longer term, especially as many potential outcome meaespecially as many potential outcome measures could be collected routinely. Observasures could be collected routinely. Observational studies have design faults that limit tional studies have design faults that limit their interpretation (Table 1) . Most importheir interpretation (Table 1) . Most importantly, true randomisation cannot occur in tantly, true randomisation cannot occur in an observational study. However, the an observational study. However, the strengths of observational studies mirror strengths of observational studies mirror the weaknesses of RCTs, and it is for this the weaknesses of RCTs, and it is for this reason that National Institute for Health reason that National Institute for Health and Clinical Excellence (NICE) has argued and Clinical Excellence (NICE) has argued for well-conducted observational studies for well-conducted observational studies to demonstrate effectiveness. Observational to demonstrate effectiveness. Observational studies might also represent the only methstudies might also represent the only method for studying certain aspects of treatment od for studying certain aspects of treatment when masking is not possible or ethical when masking is not possible or ethical concerns preclude randomisation (Cook & concerns preclude randomisation (Cook & Campbell, 1979) . Indeed, in service evaluaCampbell, 1979). Indeed, in service evaluation studies randomisation may interfere tion studies randomisation may interfere with the dependent variable and observawith the dependent variable and observational studies often exploit service inequaltional studies often exploit service inequalities (Dean ities (Dean et al et al, 1993) . Another potential , 1993). Another potential bias in observational studies is rating bias, bias in observational studies is rating bias, although although the SOHO study has shown high the SOHO study has shown high correlations between clinician and patient correlations between clinician and patient ratings. With end-points such as hospitaliratings. With end-points such as hospitalisation, bias is minimised, especially if these sation, bias is minimised, especially if these data are collected routinely (Hodgson data are collected routinely (Hodgson et al et al, , 2001 (2000) challenge the accepted hierarchy of clinical designs by reviewing outcomes clinical designs by reviewing outcomes from various methodologies in a variety of from various methodologies in a variety of study areas and conclude that observational study areas and conclude that observational studies neither over-nor underestimate studies neither over-nor underestimate treatment effects to any significant degree. treatment effects to any significant degree. They opine that observational studies are They opine that observational studies are more likely to produce homogeneous remore likely to produce homogeneous results as they include a broad spectrum of sults as they include a broad spectrum of the population at risk. In addition, there is the population at risk. In addition, there is less chance of systematic treatment biases less chance of systematic treatment biases because of the broad treatment population. because of the broad treatment population.
Recent observational studies Recent observational studies
The CATIE study (Lieberman The CATIE study (Lieberman et al et al, 2005) , , 2005), an RCT sponsored by the National Institute an RCT sponsored by the National Institute of Mental Health, compared the outcome of Mental Health, compared the outcome of atypical antipsychotics with the typical of atypical antipsychotics with the typical antipsychotic perphenazine and also incorantipsychotic perphenazine and also incorporated a switching strategy to evaluate porated a switching strategy to evaluate clozapine. The results mirror those of clozapine. The results mirror those of Tiihonen Tiihonen et al et al (2006) in that clozapine (2006) in that clozapine and olanzapine were the only oral atypical and olanzapine were the only oral atypical antipsychotics to demonstrate lower disantipsychotics to demonstrate lower discontinuation rates when compared with continuation rates when compared with oral first-generation and other secondoral first-generation and other secondgeneration antipsychotics. The study generation antipsychotics. The study reported by Tiihonen reported by Tiihonen et al et al (2006) is particu- (2006) is particularly noteworthy as it follows a nationwide larly noteworthy as it follows a nationwide cohort of over 2000 people with firstcohort of over 2000 people with firstepisode schizophrenia for up to 7 years. In episode schizophrenia for up to 7 years. In addition to showing differences in rehospiaddition to showing differences in rehospitalisation and relapse rates between comtalisation and relapse rates between commonly available antipsychotics in Finland, monly available antipsychotics in Finland, it also shows the effectiveness of mediit also shows the effectiveness of medication in reducing suicide and physical cation in reducing suicide and physical morbidity (adjusted relative risk 37.4, morbidity (adjusted relative risk 37.4, 95% CI 5.1-276 and 12.3, 95% CI 6.0-95% CI 5.1-276 and 12.3, 95% CI 6.0-24.1 respectively). The relative therapeutic 24.1 respectively). The relative therapeutic effects of the drugs studied did not vary effects of the drugs studied did not vary s 8 0 s 8 0 whether discontinuation or rehospitalisawhether discontinuation or rehospitalisation was considered, and this is echoed in tion was considered, and this is echoed in the SOHO study (Haro the SOHO study (Haro et al et al, 2006) . , 2006). Another long-term study of over 500 Another long-term study of over 500 patients in England (Hodgson patients in England (Hodgson et al et al, 2005) , 2005) demonstrated the same rank order of effecdemonstrated the same rank order of effectiveness of oral atypicals using medication tiveness of oral atypicals using medication discontinuation as an outcome. In this discontinuation as an outcome. In this study it was apparent that clozapine was study it was apparent that clozapine was being used for a treatment-resistant cohort. being used for a treatment-resistant cohort. Taylor Taylor open-label study of atypical antipsychotics and haloperidol in in-patients using the and haloperidol in in-patients using the Brief Psychiatric Rating Scale (BPRS; Brief Psychiatric Rating Scale (BPRS; Overall & Gorham, 1962 ) and time to disOverall & Gorham, 1962) and time to discharge as outcome measures found similar charge as outcome measures found similar effectiveness between haloperidol, olanzaeffectiveness between haloperidol, olanzapine and risperidone and that these drugs pine and risperidone and that these drugs were significantly better than aripiprazole were significantly better than aripiprazole and quetiapine. However, there was a and quetiapine. However, there was a dissonance between time to discharge and dissonance between time to discharge and the BPRS outcomes, which might suggest the BPRS outcomes, which might suggest that rating instruments are not sensitive to that rating instruments are not sensitive to important changes that influence manageimportant changes that influence management, at least in the short term. Although ment, at least in the short term. Although haloperidol was equal to risperidone and haloperidol was equal to risperidone and olanzapine it was associated with more olanzapine it was associated with more extrapyramidal side-effects. Jones extrapyramidal side-effects. Jones et al et al (2006) failed to detect any differences in (2006) failed to detect any differences in effectiveness between first-and secondeffectiveness between first-and secondgeneration antipsychotics and reported no generation antipsychotics and reported no difference in extrapyramidal-type sidedifference in extrapyramidal-type sideeffects, in stark contrast to many other effects, in stark contrast to many other RCTs. A recent RCT of 400 first-episode RCTs. A recent RCT of 400 first-episode patients (McEvoy patients (McEvoy et al et al, 2006 (McEvoy et al et al, ) compared , 2006 ) compared olanzapine, quetiapine and risperidone over olanzapine, quetiapine and risperidone over 1 year and failed to detect a difference in 1 year and failed to detect a difference in discontinuation rates between these drugs discontinuation rates between these drugs although olanzapine had a significantly although olanzapine had a significantly greater effect on positive symptoms. Disgreater effect on positive symptoms. Discontinuation was associated with poor recontinuation was associated with poor response ( sponse (P P5 50.001) and poor medication 0.001) and poor medication adherence ( adherence (P P¼0.02). 0.02).
In general, RCTs are powered for one In general, RCTs are powered for one primary outcome which does not always primary outcome which does not always reflect primary clinical concern (McQuade reflect primary clinical concern (McQuade et al et al, 2004) . As observational studies are , 2004). As observational studies are larger, there is more scope for legitimate larger, there is more scope for legitimate subgroup analysis, such as treatment effect subgroup analysis, such as treatment effect on those with comorbid disorder. The 3-on those with comorbid disorder. The 3-year results of the SOHO study provide year results of the SOHO study provide insights into social function and factors asinsights into social function and factors associated with relapse and remission. These sociated with relapse and remission. These are consonant with other independent stuare consonant with other independent studies and increase the face validity of this dies and increase the face validity of this study. Although the SOHO study demonstudy. Although the SOHO study demonstrates relatively high switching rates for strates relatively high switching rates for some medications, 65% of patients some medications, 65% of patients achieved remission, which resonates with achieved remission, which resonates with the results of other long-term studies the results of other long-term studies (Ciompi, 1980; Harding, 1988) . (Ciompi, 1980; Harding, 1988) .
Observational studies and safety Observational studies and safety
Although often not acknowledged as such, Although often not acknowledged as such, post-marketing surveillance is essentially post-marketing surveillance is essentially an observational study, albeit often poorly an observational study, albeit often poorly conducted (Vray conducted (Vray et al et al, 2005) . However, , 2005). However, post-marketing surveillance often reports post-marketing surveillance often reports important safety information that was not important safety information that was not s 81 s 81 AUTHOR'S PROOF AUTHOR'S PROOF 
COMMON COMMON METHODOLOGICAL ISSUES METHODOLOGICAL ISSUES Analysis Analysis
Both RCTs and observational studies preBoth RCTs and observational studies present difficulties in analysis. In RCTs high sent difficulties in analysis. In RCTs high attrition rates have led to intention-to-treat attrition rates have led to intention-to-treat analyses with a variety of statistical technianalyses with a variety of statistical techniques evolving to accommodate these drop ques evolving to accommodate these drop outs. These include last-observation-carriedouts. These include last-observation-carriedforward (LOCF) analysis and mixed model forward (LOCF) analysis and mixed model repeated measures (MMRM); LOCF asrepeated measures (MMRM); LOCF assumes that data are missing completely at sumes that data are missing completely at random and that the patient's condition random and that the patient's condition would remain constant; both assumptions would remain constant; both assumptions are unlikely; MMRM is valid under less are unlikely; MMRM is valid under less restrictive assumptions with use of missing restrictive assumptions with use of missing data dependent on other measured factors data dependent on other measured factors (Mallinckrodt (Mallinckrodt et al et al, 2003) . , 2003). Randomised controlled trials have Randomised controlled trials have highlighted relatively high switching rates highlighted relatively high switching rates between therapies and potentially conbetween therapies and potentially confounding baseline variation, with lower founding baseline variation, with lower rates measured in observational studies. rates measured in observational studies. Baseline variation can be accommodated Baseline variation can be accommodated in analysis but, as with drop out from in analysis but, as with drop out from RCTs, it cannot be assumed that this variaRCTs, it cannot be assumed that this variation is random and may reflect clinical tion is random and may reflect clinical practice. For example, in the study reported practice. For example, in the study reported by Hodgson by Hodgson et al et al, (2005) and the SOHO , (2005) and the SOHO study (Haro study (Haro et al et al, 2006) young men with , 2006) young men with multiple illness episodes were more likely multiple illness episodes were more likely to receive clozapine. to receive clozapine.
Switching treatments within an obserSwitching treatments within an observational study can be studied using marginal vational study can be studied using marginal structural models (MSM), a new class of structural models (MSM), a new class of causal models that allow for improved causal models that allow for improved adjustment of confounding in longitudinal adjustment of confounding in longitudinal data analysis in naturalistic settings by data analysis in naturalistic settings by consistently estimating the parameters of the consistently estimating the parameters of the inverse-probability-of-treatment weighted inverse-probability-of-treatment weighted estimators (Mortimer estimators (Mortimer et al et al, 2005) ; MSM , 2005); MSM are an extension of propensity scoring to are an extension of propensity scoring to longitudinal data. Whereas propensity longitudinal data. Whereas propensity scoring controls for selection bias by rescoring controls for selection bias by reweighting weighting observations to produce 'balance' observations to produce 'balance' between groups, MSM do the same but in between groups, MSM do the same but in a longitudinal fashion; MSM allow estima longitudinal fashion; MSM allow estimation of the causal effect of treatments in ation of the causal effect of treatments in longitudinal naturalistic data when patients longitudinal naturalistic data when patients switch or stop treatment, even in the switch or stop treatment, even in the presence of missing (at random) data and presence of missing (at random) data and time-varying confounding variables. time-varying confounding variables.
Patient concordance Patient concordance and sample size and sample size
In estimating treatment effects both RCTs In estimating treatment effects both RCTs and observational studies are challenged and observational studies are challenged by patient concordance. Drug levels, which by patient concordance. Drug levels, which are highly variable for many psychotropics, are highly variable for many psychotropics, are not routinely used, with pill counting are not routinely used, with pill counting being a common concordance measure in being a common concordance measure in RCTs. However, poor adherence may RCTs. However, poor adherence may underestimate treatment effects. Patient underestimate treatment effects. Patient and clinician choice is important in deterand clinician choice is important in determining outcome (Black, 1996) and controlmining outcome (Black, 1996) and controlling for these variables in RCTs limits the ling for these variables in RCTs limits the exploration of these factors. Zelen (1979) exploration of these factors. Zelen (1979) has advocated a methodology that has the has advocated a methodology that has the advantage that, before providing consent, a advantage that, before providing consent, a patient will know whether an experimental patient will know whether an experimental treatment is to be used. Further development treatment is to be used. Further development of patient and clinician preference trials has of patient and clinician preference trials has been described (Korn & Baumrind, 1991 The nature of observational studies The nature of observational studies allows large sample sizes that add to the allows large sample sizes that add to the power of the study, facilitate subgroup anapower of the study, facilitate subgroup analysis and provide data for robust sample lysis and provide data for robust sample size estimates for RCTs. Although in gensize estimates for RCTs. Although in general appropriate sample sizes are important eral appropriate sample sizes are important in RCTs, the superiority of those with large in RCTs, the superiority of those with large sample sizes over those with smaller sample sizes over those with smaller samples has been challenged with regard samples has been challenged with regard to overestimating treatment effects to overestimating treatment effects (Contopoulos-Ioannidis (Contopoulos-Ioannidis et al et al, 2005) . , 2005).
Publication bias and sponsorship Publication bias and sponsorship
Publication bias might also affect the two Publication bias might also affect the two methodologies. Given the hierarchy of methodologies. Given the hierarchy of evidence, journals may be less willing to evidence, journals may be less willing to accept observational studies (Barton, accept observational studies (Barton, 2000) . Journals are less likely to publish 2000). Journals are less likely to publish negative studies and both methodologies negative studies and both methodologies are potentially biased by the study sponsor, are potentially biased by the study sponsor, with positive results often being associated with positive results often being associated with the vested interest of the sponsor with the vested interest of the sponsor (Als-Nielsen (Als-Nielsen et al et al, 2003) . However, a , 2003) . However, a review of atypical antipsychotic trials review of atypical antipsychotic trials and funding sources indicates that this is and funding sources indicates that this is not invariably so (Heres not invariably so (Heres et al et al, 2006) . , 2006). Moreover, government-funded trials cannot Moreover, government-funded trials cannot be assumed to be unbiased (Coyne, 2006) be assumed to be unbiased (Coyne, 2006) 
THE WAY FORWARD THE WAY FORWARD
The pre-eminence of RCTs and regulatory The pre-eminence of RCTs and regulatory requirements has led to maintenance of requirements has led to maintenance of the status quo in clinical drug trial developthe status quo in clinical drug trial development. Once a drug receives its marketing ment. Once a drug receives its marketing authorisation then further trial work is authorisation then further trial work is often aimed at developing markets rather often aimed at developing markets rather than ascertaining whether the drug is effecthan ascertaining whether the drug is effective. These concerns are just as relevant to tive. These concerns are just as relevant to psychotherapy and other non-pharmacopsychotherapy and other non-pharmacological interventions. Making the trials as logical interventions. Making the trials as much like routine practice as possible much like routine practice as possible may may help to make RCTs more feasible help to make RCTs more feasible and enand enhance external validity (so-called pragmatic hance external validity (so-called pragmatic trials; Hotopf, 2002) . Although pragmatic trials; Hotopf, 2002) . Although pragmatic trials may eschew some features of RCTs, trials may eschew some features of RCTs, such as double blinding, careful considersuch as double blinding, careful consideration may significantly reduce bias (Schulz ation may significantly reduce bias (Schulz et al et al, 1995) . Patient recruitment is broad , 1995). Patient recruitment is broad and may not be diagnostically driven (e.g. and may not be diagnostically driven (e.g. frequent attendees at a general practitioner frequent attendees at a general practitioner surgery or people who self-harm). Outsurgery or people who self-harm). Outcomes, such as a reduction in suicide or comes, such as a reduction in suicide or episodes of violence, are clinically signifiepisodes of violence, are clinically significant. Patient preference is an important cant. Patient preference is an important variable in treatment choice which is variable in treatment choice which is negated in a traditional RCT, but patient negated in a traditional RCT, but patient preference trials have been reported preference trials have been reported (Ward (Ward et al et al, 2000) and may be particularly , 2000) and may be particularly relevant when masking is not possible. The relevant when masking is not possible. The CATIE study (Lieberman CATIE study (Lieberman et al et al, 2005) has , 2005) has many features of a pragmatic trial, such as many features of a pragmatic trial, such as narrow exclusion criteria and medication narrow exclusion criteria and medication discontinuation as an outcome. discontinuation as an outcome.
Randomised controlled trials and obRandomised controlled trials and observational studies are not mutually excluservational studies are not mutually exclusive, and there are examples from other sive, and there are examples from other areas of medicine of two designs running areas of medicine of two designs running in parallel. For example, several studies in parallel. For example, several studies quoted in Benson & Hartz (2000) in coronquoted in Benson & Hartz (2000) in coronary artery disease illustrate the merits of ary artery disease illustrate the merits of enhancing an RCT by the addition of enhancing an RCT by the addition of observational data from a concurrent regisobservational data from a concurrent registry of all non-randomised patients in the try of all non-randomised patients in the same centres. This approach improves the same centres. This approach improves the quality quality of observational research, since the of observational research, since the same rigorous attention to detail in defining same rigorous attention to detail in defining eligible patients, maintaining follow-up eligible patients, maintaining follow-up and and recording outcomes is applied in both the recording outcomes is applied in both the randomised and the observational cohorts. randomised and the observational cohorts. The observational cohort may still The observational cohort may still suffer suffer from selection bias, but there is a greater from selection bias, but there is a greater likelihood that its causes can be identified. likelihood that its causes can be identified. The corollary also applies in that the The corollary also applies in that the s 8 2 s 8 2 observational cohort inform on the typicality observational cohort inform on the typicality of the experimental group. of the experimental group.
Rapid changes in methodologies withRapid changes in methodologies without bridging links with older methodologies out bridging links with older methodologies may preclude legitimate comparison and submay preclude legitimate comparison and subsequent meta-analysis. However, advances sequent meta-analysis. However, advances in the understanding of the biological and in the understanding of the biological and psychological mechanisms of mental illness psychological mechanisms of mental illness will also dictate the evolution of relevant will also dictate the evolution of relevant end-points. This is typified by the increasend-points. This is typified by the increasing interest in cognitive outcomes (Stroup ing interest in cognitive outcomes (Stroup et al et al, 2003) for which NICE recommends , 2003) for which NICE recommends audits and provides standardised templates. audits and provides standardised templates. This is another potential for supplementing This is another potential for supplementing treatment information and should facilitate treatment information and should facilitate the collection of data pools that inform the collection of data pools that inform treatment practice. The introduction of treatment practice. The introduction of new treatment presents the possibility of new treatment presents the possibility of mirror image studies (Hodgson mirror image studies (Hodgson et al et al, , 2002 ) that allow some measure of utility, 2002) that allow some measure of utility, although regression towards the mean prealthough regression towards the mean precludes overinterpretation of the results. cludes overinterpretation of the results.
CONCLUSIONS CONCLUSIONS
The RCT has served medicine well but The RCT has served medicine well but evaluation of treatment needs reviewing evaluation of treatment needs reviewing for the 21st century. Outcomes need to be for the 21st century. Outcomes need to be more clinically relevant and comparable more clinically relevant and comparable with those from other trial methodologies. with those from other trial methodologies. Biases in recruitment need to be addressed Biases in recruitment need to be addressed and post-marketing surveillance needs a and post-marketing surveillance needs a more robust approach, as does monitoring more robust approach, as does monitoring of fidelity to treatment or service delivery of fidelity to treatment or service delivery models. In part this could be achieved with models. In part this could be achieved with naturalistic studies, audits and mirror naturalistic studies, audits and mirror image studies. Without such additional image studies. Without such additional information, treatments cannot be tailored information, treatments cannot be tailored effectively to the patient. Dogma should effectively to the patient. Dogma should not be allowed to drive the experimental not be allowed to drive the experimental paradigm agenda as no current research paradigm agenda as no current research design provides comprehensive clinical design provides comprehensive clinical information. information. 
